Holocene Advisors’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,199,990
| Closed | -$19M | – | 821 |
|
2024
Q4 | $19M | Buy |
1,199,990
+356,880
| +42% | +$5.65M | 0.06% | 252 |
|
2024
Q3 | $49M | Buy |
843,110
+154,784
| +22% | +$8.99M | 0.2% | 147 |
|
2024
Q2 | $31.5M | Buy |
688,326
+50,343
| +8% | +$2.3M | 0.13% | 175 |
|
2024
Q1 | $42.2M | Buy |
+637,983
| New | +$42.2M | 0.16% | 164 |
|